| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,818 |
1,549 |
$26K |
| 62323 |
|
179 |
142 |
$21K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,866 |
2,288 |
$10K |
| 85014 |
|
2,559 |
1,850 |
$9K |
| 85018 |
|
2,556 |
1,840 |
$8K |
| 80051 |
|
1,438 |
1,021 |
$8K |
| 82540 |
|
1,460 |
1,027 |
$6K |
| 84520 |
|
1,449 |
1,024 |
$4K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
191 |
171 |
$3K |
| 82947 |
|
1,309 |
951 |
$3K |
| 86901 |
|
488 |
428 |
$2K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
12 |
12 |
$2K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
636 |
524 |
$1K |
| 82948 |
|
185 |
112 |
$1K |
| 86900 |
|
536 |
469 |
$955.31 |
| 82575 |
|
498 |
441 |
$621.53 |
| 87081 |
|
528 |
467 |
$603.23 |
| 85610 |
|
382 |
338 |
$434.70 |
| 85730 |
|
358 |
319 |
$410.30 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
289 |
247 |
$332.88 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
23 |
12 |
$270.71 |
| 86850 |
|
510 |
450 |
$220.00 |
| 36415 |
Collection of venous blood by venipuncture |
494 |
365 |
$80.00 |
| 97161 |
|
62 |
44 |
$30.41 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,998 |
1,515 |
$22.28 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
2,195 |
1,832 |
$13.01 |
| 97116 |
|
71 |
33 |
$9.15 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,204 |
1,003 |
$7.59 |
| J2704 |
Injection, propofol, 10 mg |
688 |
573 |
$3.33 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
451 |
321 |
$2.29 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
68 |
40 |
$0.00 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
32 |
27 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
117 |
48 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
133 |
101 |
$0.00 |
| 76942 |
|
16 |
14 |
$0.00 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
497 |
333 |
$0.00 |
| C1776 |
Joint device (implantable) |
16 |
13 |
$0.00 |
| 76000 |
|
13 |
13 |
$0.00 |